Next-Generation Sequencing
Molecular Profiling in Pediatric Cancer Trials Continues to Prove Valuable for Treatment Matching
Premium
The GAIN/iCat2 study and the Pediatric MATCH trial showed that molecular data has a significant impact on treatment recommendations for kids with cancer.
Hummingbird Bioscience, Novogene Partner to ID Cancer Patients With NRG1 Fusions in China
Novogene will use next-generation sequencing to identify solid tumor patients eligible to enroll in clinical trials of Hummingbird's anti-HER3 agent, HMBD-001.
Researchers used real-world data to identify low NGS testing rates, particularly among Black patients, suggesting many aren't getting precision medical treatment.
Lucence Presents New Data on Liquid Biopsy for Late-Stage Cancer Monitoring, Treatment Guidance
Premium
The firm shared validation data at ASCO on its LiquidHallmark assay to help guide detection and treatment decisions for late-stage cancers.
Global Subway Metagenomics Study Reveals Cities' Microbial Fingerprints
The study found more than 10,000 viruses and hundreds of bacteria not present in any reference database, along with other novel genomic features.